{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:32:51Z","timestamp":1779921171170,"version":"3.53.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41409-024-02500-2","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:39:33Z","timestamp":1734719973000},"page":"380-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimal timing and impact of allogeneic peripheral blood stem cell transplantation in adult T-cell lymphoblastic lymphoma: insights from a large cohort multi-center real-world study in Shanghai"],"prefix":"10.1038","volume":"60","author":[{"given":"Fangfang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siguo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8978-1987","authenticated-orcid":false,"given":"Aibin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-4007","authenticated-orcid":false,"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5766-1625","authenticated-orcid":false,"given":"Rong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0637-5324","authenticated-orcid":false,"given":"Xianmin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"2500_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","volume":"113","author":"S Cortelazzo","year":"2017","unstructured":"Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304\u201317.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2500_CR2","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. vol 2. International agency for research on cancer Lyon, France; 2008."},{"key":"2500_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","volume":"104","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, O\u2019Brien S, Cortes J, Giles FJ, Faderl S, Verstovsek S, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004;104:1624\u201330.","journal-title":"Blood"},{"key":"2500_CR4","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","volume":"99","author":"D Hoelzer","year":"2002","unstructured":"Hoelzer D, G\u00f6kbuget N, Digel W, Faak T, Kneba M, Reutzel R, et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood. 2002;99:4379\u201385.","journal-title":"Blood"},{"key":"2500_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009;27:911\u20138.","journal-title":"J Clin Oncol"},{"key":"2500_CR6","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","volume":"27","author":"B Burkhardt","year":"2009","unstructured":"Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, et al. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin-Frankfurt-Muenster group. J Clin Oncol. 2009;27:3363\u20139.","journal-title":"J Clin Oncol"},{"key":"2500_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/annonc\/mdl426","volume":"18","author":"KW Song","year":"2007","unstructured":"Song KW, Barnett MJ, Gascoyne RD, Chhanabhai M, Forrest DL, Hogge DE, et al. Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes. Ann Oncol. 2007;18:535\u201340.","journal-title":"Ann Oncol"},{"key":"2500_CR8","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s41409-018-0184-7","volume":"53","author":"L Yang","year":"2018","unstructured":"Yang L, Tan Y, Shi J, Zhao Y, Zhu Y, Hu Y, et al. Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma. Bone Marrow Transpl. 2018;53:1340\u20134.","journal-title":"Bone Marrow Transpl"},{"key":"2500_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1193237","volume":"13","author":"Z Li","year":"2023","unstructured":"Li Z, Zhang B, Fan X, Gui R, Yu F, Wang J, et al. Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma. Front Oncol. 2023;13:1193237.","journal-title":"Front Oncol"},{"key":"2500_CR10","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1182\/blood-2002-05-1483","volume":"101","author":"JE Levine","year":"2003","unstructured":"Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2003;101:2476\u201382.","journal-title":"Blood"},{"key":"2500_CR11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3324\/haematol.10882","volume":"92","author":"M Hunault","year":"2007","unstructured":"Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, et al. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial. Haematologica. 2007;92:1623\u201330.","journal-title":"Haematologica"},{"key":"2500_CR12","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00277-024-05719-7","volume":"103","author":"L Luo","year":"2024","unstructured":"Luo L, Jiao Y, Li Y, Yang P, Gao J, Huang S, et al. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia \/lymphoma: a large cohort multicenter study in China. Ann Hematol. 2024;103:2073\u201387.","journal-title":"Ann Hematol"},{"key":"2500_CR13","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"2500_CR14","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1111\/ajco.12610","volume":"13","author":"Y Shi","year":"2017","unstructured":"Shi Y, Liu P, Zhou S, Yang J, Han X, He X, et al. Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity. Asia Pac J Clin Oncol. 2017;13:e423\u2013e429.","journal-title":"Asia Pac J Clin Oncol"},{"key":"2500_CR15","doi-asserted-by":"crossref","unstructured":"Niu J, Chen Z, Gao J, Qiu H, Wan L, Wang Y, et al. Total body irradiation-based conditioning regimen improved the survival of adult patients with T-Cell lymphoblastic lymphoma after allogeneic peripheral blood stem cell transplantation. Cell Transpl. 2022;31:9636897221108890.","DOI":"10.1177\/09636897221108890"},{"key":"2500_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41409-020-01047-2","volume":"56","author":"X Xu","year":"2021","unstructured":"Xu X, Yang J, Cai Y, Li S, Niu J, Zhou K, et al. Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG\/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood. Bone Marrow Transpl. 2021;56:705\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2500_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41409-018-0382-3","volume":"54","author":"J Yang","year":"2019","unstructured":"Yang J, Jiang J, Cai Y, Li S, Wan L, Zhu J, et al. Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study. Bone Marrow Transpl. 2019;54:1049\u201357.","journal-title":"Bone Marrow Transpl"},{"key":"2500_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/neuonc\/noy192","volume":"21","author":"C Grommes","year":"2019","unstructured":"Grommes C, Rubenstein JL, DeAngelis LM, Ferreri AJM, Batchelor TT. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro Oncol. 2019;21:296\u2013305.","journal-title":"Neuro Oncol"},{"key":"2500_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.4143\/crt.2019.542","volume":"52","author":"C Li","year":"2020","unstructured":"Li C, Wuxiao ZJ, Chen X, Chen G, Lu Y, Xia Z, et al. A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in adult patients with T-Lymphoblastic lymphoma, a two-institution experience. Cancer Res Treat. 2020;52:573\u201385.","journal-title":"Cancer Res Treat"},{"key":"2500_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10:147\u201356.","journal-title":"Lancet Oncol"},{"key":"2500_CR21","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"2500_CR22","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. Consensus conference on acute GVHD grading. Bone Marrow Transpl. 1995;15:825\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2500_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.bbmt.2015.05.004","volume":"21","author":"PJ Martin","year":"2015","unstructured":"Martin PJ, Lee SJ, Przepiorka D, Horowitz MM, Koreth J, Vogelsang GB, et al. National Institutes of Health Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. The 2014 clinical trial design working group report. Biol Blood Marrow Transpl. 2015;21:1343\u201359.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2500_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","volume":"34","author":"S Lepretre","year":"2016","unstructured":"Lepretre S, Touzart A, Vermeulin T, Picquenot JM, Tanguy-Schmidt A, Salles G, et al. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study. J Clin Oncol. 2016;34:572\u201380.","journal-title":"J Clin Oncol"},{"key":"2500_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00277-014-2258-y","volume":"94","author":"SH Jeong","year":"2015","unstructured":"Jeong SH, Moon JH, Kim JS, Yang DH, Park Y, Cho SG, et al. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation. Ann Hematol. 2015;94:617\u201325.","journal-title":"Ann Hematol"},{"key":"2500_CR26","doi-asserted-by":"publisher","first-page":"38884","DOI":"10.18632\/oncotarget.9144","volume":"7","author":"MY Zhu","year":"2016","unstructured":"Zhu MY, Wang H, Huang CY, Xia ZJ, Chen XQ, Geng QR, et al. A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma. Oncotarget. 2016;7:38884\u201391.","journal-title":"Oncotarget"},{"key":"2500_CR27","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","volume":"127","author":"N Jain","year":"2016","unstructured":"Jain N, Lamb AV, O\u2019Brien S, Ravandi F, Konopleva M, Jabbour E, et al. Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127:1863\u20139.","journal-title":"Blood"},{"key":"2500_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ajh.26144","volume":"96","author":"K Morita","year":"2021","unstructured":"Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, et al. Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine. Am J Hematol. 2021;96:589\u201398.","journal-title":"Am J Hematol"},{"key":"2500_CR29","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/ccr3.3041","volume":"8","author":"E Zappone","year":"2020","unstructured":"Zappone E, Cencini E, Defina M, Sicuranza A, Gozzetti A, Ciofini S, et al. Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia. Clin Case Rep. 2020;8:2000\u20132.","journal-title":"Clin Case Rep"},{"key":"2500_CR30","doi-asserted-by":"crossref","unstructured":"Numan Y, Alfayez M, Maiti A, Alvarado Y, Jabbour EJ, Ferrajoli A, et al. First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia. JCO Precis Oncol. 2018;2:PO.18.00127.","DOI":"10.1200\/PO.18.00127"},{"key":"2500_CR31","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","volume":"4","author":"TN Chonghaile","year":"2014","unstructured":"Chonghaile TN, Roderick JE, Glenfield C, Ryan J, Sallan SE, Silverman LB, et al. Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199. Cancer Discov. 2014;4:1074\u201387.","journal-title":"Cancer Discov"},{"key":"2500_CR32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood. 2008;111:1827\u201333.","journal-title":"Blood"},{"key":"2500_CR33","volume":"4","author":"M Lv","year":"2023","unstructured":"Lv M, Shen M, Mo X. Development of allogeneic hematopoietic stem cell transplantation in 2022: Regenerating \u201cGroot\u201d to heal the world. Innovation. 2023;4:100373","journal-title":"Innovation"},{"key":"2500_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/bjh.12239","volume":"161","author":"J Hochberg","year":"2013","unstructured":"Hochberg J, Khaled S, Forman SJ, Cairo MS. Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission. Br J Haematol. 2013;161:27\u201342.","journal-title":"Br J Haematol"},{"key":"2500_CR35","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(87)92809-1","volume":"1","author":"RH Herzig","year":"1987","unstructured":"Herzig RH, Bortin MM, Barrett AJ, Blume KG, Gluckman E, Horowitz MM, et al. Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. Lancet. 1987;1:786\u20139.","journal-title":"Lancet"},{"key":"2500_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.hoc.2014.08.008","volume":"28","author":"DI Marks","year":"2014","unstructured":"Marks DI, Alonso L, Radia R. Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2014;28:995\u20131009.","journal-title":"Hematol Oncol Clin North Am"},{"key":"2500_CR37","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1182\/blood.2022018653","volume":"141","author":"NP Gossai","year":"2023","unstructured":"Gossai NP, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, Rabin KR, et al. Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children\u2019s Oncology Group report. Blood. 2023;141:1802\u201311.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02500-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02500-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02500-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:03:15Z","timestamp":1741633395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02500-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2500"],"URL":"https:\/\/doi.org\/10.1038\/s41409-024-02500-2","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving humans were approved by Ethics Committee of Shanghai General Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants\u2019 legal guardians\/next of kin in accordance with national legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}